1. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
- Author
-
De Fanis U, Romano C, Dalla Mora L, Sellitto A, Guastafierro S, Tirelli A, Bresciano E, Giunta R, and Lucivero G
- Subjects
- Aged, Antigens, Differentiation, B-Lymphocyte metabolism, Apoptosis drug effects, B-Lymphocytes pathology, Carcinogens pharmacology, Case-Control Studies, Female, Humans, Immunophenotyping, Ionomycin pharmacology, Ionophores pharmacology, Lectins, C-Type, Lymphocyte Activation drug effects, Male, Phytohemagglutinins pharmacology, Pokeweed Mitogens pharmacology, Tetradecanoylphorbol Acetate pharmacology, Up-Regulation, Antigens, CD metabolism, Antigens, Differentiation, T-Lymphocyte metabolism, B-Lymphocytes metabolism, Leukemia, Lymphocytic, Chronic, B-Cell metabolism, fas Receptor metabolism
- Abstract
B-cell chronic lymphocytic leukemia (B-CLL) is characterized by a sustained accumulation of long-lived and well-differentiated B lymphocytes in lymphoid tissues, peripheral blood and bone marrow. Although the pathogenesis of this disease is not entirely understood, altered apoptosis is believed to play a relevant role in B-CLL. In this study, we compared the expression of CD95, the best characterized surface molecule involved in triggering the apoptotic machinery, on normal and CLL B cells before and after in vitro activation with polyclonal stimulators. Cell activation was monitored by verifying the induced expression of the early activation antigen CD69. Freshly analyzed CLL B cells showed significantly lower levels of CD95 than normal B cells. Moreover, following in vitro culture with phorbol 12-myristate 13-acetate (PMA) + ionomycin, phytohemagglutinin, or pokeweed mitogen, CLL B cells failed to upregulate CD95 expression as efficiently as normal B cells. Impairment of CD95 upregulation was mainly observed following PMA + ionomycin treatment. In contrast, CLL B cells were shown to express CD69 as well as normal B cells, regardless of the activator used, indicating that CLL B cells retain the ability to respond to activating stimuli but are unable to efficiently implement the CD95-mediated activation-induced cell death (AICD) program. In conclusion, these results suggest that prolonged survival of CLL B cells may be contributed to by alterations in AICD mechanisms.
- Published
- 2003